Article · 24 Dec 2025
Review articlePublished 2012
Allergic Rhinitis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Allergic rhinitis (AR) has a negative impact on the quality of life and its incidence and prevalence is increasing worldwide. Depending on the sensitization pattern, patients may develop seasonal- or perennial symptoms: seasonal rhinitis is caused by aeroallergens such as pollens while the perennial form is mostly induced by mites, mold, and dander. In many cases allergen avoidance may contribute significantly to reduce the use of medications. The most common agents to treat AR include antihistamines, decongestants, steroids, mast cell stabilizers, anticholinergic agents, antileukotrienes and mucolytics: topical corticosteroids are the preferred method of treatment for both seasonal and perennial allergic rhinitis. Specific allergen immunotherapy should be considered when there is a poor response to pharmacotherapy, particularly as it is effective and modifies the course of the disease. A clear advantage of SIT over pharmacotherapy, the benefits of which last as long as it is continued, is a long-lasting relief of allergic symptoms after treatment discontinuation. Novel forms of SIT are currently under investigation including peptide vaccine using T cell epitopes, recombinant hypoallergenic allergens, and conjugated DNA vaccines.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 1 Sep 2025
Understanding the Pathophysiology and Treatment Approaches for Allergic Rhinitis in Global Populations
Article · 29 Mar 2024
Allergic Rhinitis: Pathogenesis and Management Strategies
Rapid communication · 27 Jan 2024
Unmasking allergic rhinitis: The th2 cytokine symphony in nasal inflammation
Article · 30 Dec 2023
Allergic Rhinitis and Immune System Targeting: Significance for the Development of Immunotherapy
More from this journal
The newest in Journal of Allergy & Therapy.
Article · 29 Jun 2026
Allergy Diagnostics Innovation: Advancing Precision Identification of Immune Responses
Article · 29 Jun 2026
Immunomodulatory Therapeutics: Advancing Immune System Control Through Targeted Medical Strategies
Article · 29 Jun 2026
Immunoglobulin E (IgE) Regulation: Understanding Molecular Control of Allergic Immune Responses
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Allergy & Therapy
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Ramírez-Jiménez F”
- BylineArticles whose byline prints “Pavón-Romero G”
- BylineArticles whose byline prints “Juárez-Martínez LL”
- BylineArticles whose byline prints “Terán LM”

